Gebauer Julie Jarecke

SEC source: 0001127602-23-022246 · form4.xml · derivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,853.5635

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 131.6864 shares

Expires not disclosed

F1 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F2 · shares: Includes restricted share units acquired pursuant to the Company's contribution under the terms of the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account.

F1 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F1 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

SEC source: 0001127602-23-021183 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,603.26

F1 · shares: Withholding of shares by Issuer incident to the vesting and settlement of an aggregate of 4,728 performance-based restricted share units on July 20, 2023.

SEC source: 0001127602-23-021046 · form4.xml · derivative · entry 6

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14.96

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 2.963 shares

Expires not disclosed

F1 · derivative.exercise_price: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · shares: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.exercise_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.expiration_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

SEC source: 0001127602-23-021046 · form4.xml · derivative · entry 5

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,721.8771

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 17.2093 shares

Expires not disclosed

F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F5 · shares: Represents dividends acquired pursuant to the Company's contribution under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account in the form of restricted share units.

F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

SEC source: 0001127602-23-021046 · form4.xml · derivative · entry 4

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,224.5362

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 80.7561 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Represents dividends acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F2 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-23-021046 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,265.067

F1 · shares: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

SEC source: 0001127602-23-020639 · form4.xml · derivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,143.7802

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 66.6295 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-23-019981 · form4.xml · nonDerivative · entry 3

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,239.573

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F3 · price: This transaction was executed in multiple trades at prices ranging from $229.51 to $230.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-019981 · form4.xml · nonDerivative · entry 2

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,139.573

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F2 · price: This transaction was executed in multiple trades at prices ranging from $231.035 to $231.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-019981 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,739.573

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

SEC source: 0001127602-23-017339 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,239.573

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F2 · price: This transaction was executed in multiple trades at prices ranging from $218.25 to $218.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-015418 · form4.xml · derivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,704.668

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 356.2736 shares

Expires not disclosed

F1 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F2 · shares: Includes restricted share units acquired pursuant to the Company's contribution under the terms of the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account.

F1 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F1 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

SEC source: 0001127602-23-014079 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,739.573

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F2 · price: This transaction was executed in multiple trades at prices ranging from $230.73 to $231.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-013345 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,239.573

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of dividend equivalent rights on April 17, 2023.

SEC source: 0001127602-23-013246 · form4.xml · derivative · entry 8

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11.997

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 1 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The dividend equivalent rights are fully vested and accrued on a number of time-based restricted share units previously vested under the reporting person's time-based restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F2 · shares: The dividend equivalent rights are fully vested and accrued on a number of time-based restricted share units previously vested under the reporting person's time-based restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F2 · derivative.exercise_date: The dividend equivalent rights are fully vested and accrued on a number of time-based restricted share units previously vested under the reporting person's time-based restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F2 · derivative.expiration_date: The dividend equivalent rights are fully vested and accrued on a number of time-based restricted share units previously vested under the reporting person's time-based restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

SEC source: 0001127602-23-013246 · form4.xml · derivative · entry 7

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12.997

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 4.274 shares

Expires not disclosed

F7 · derivative.exercise_price: The dividend equivalent rights accrued on the reporting person's time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F7 · shares: The dividend equivalent rights accrued on the reporting person's time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F7 · derivative.exercise_date: The dividend equivalent rights accrued on the reporting person's time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F7 · derivative.expiration_date: The dividend equivalent rights accrued on the reporting person's time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

SEC source: 0001127602-23-013246 · form4.xml · derivative · entry 6

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,348.3944

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 15.2952 shares

Expires not disclosed

F5 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F6 · shares: Represents dividends acquired pursuant to the Company's contribution under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account in the form of restricted share units.

F5 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F5 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

SEC source: 0001127602-23-013246 · form4.xml · derivative · entry 5

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,077.1506

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 76.9756 shares

Expires not disclosed

F3 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F4 · shares: Represents dividends acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F3 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-23-013246 · form4.xml · nonDerivative · entry 2

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,240.573

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: The dividend equivalent rights are fully vested and accrued on a number of time-based restricted share units previously vested under the reporting person's time-based restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

SEC source: 0001127602-23-013246 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,239.573

F1 · shares: The dividend equivalent rights accrued on a number of performance-based restricted share units previously earned under the reporting person's performance-based restricted share unit award and credited in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

SEC source: 0001127602-23-012917 · form4.xml · derivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,000.175

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 193.1474 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-23-012757 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,223

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 403 restricted share units granted on April 1, 2022.

SEC source: 0001127602-23-012330 · form4.xml · nonDerivative · entry 4

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,312

F3 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F4 · price: This transaction was executed in multiple trades at prices ranging from $232.09 to $232.8845. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-012330 · form4.xml · derivative · entry 7

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9.146

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 4 shares

Expires not disclosed

F5 · derivative.exercise_price: The dividend equivalent rights accrued on the reporting person's RSU award and were credited in the form of additional RSUs that vested and were payable at the same time as the underlying RSUs. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F5 · derivative.exercise_date: The dividend equivalent rights accrued on the reporting person's RSU award and were credited in the form of additional RSUs that vested and were payable at the same time as the underlying RSUs. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F5 · derivative.expiration_date: The dividend equivalent rights accrued on the reporting person's RSU award and were credited in the form of additional RSUs that vested and were payable at the same time as the underlying RSUs. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

SEC source: 0001127602-23-012330 · form4.xml · nonDerivative · entry 3

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,812

F2 · shares: Comprised of 860 time-based RSUs which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest ratably over a two-year period as of the first and second anniversaries of the grant date.

SEC source: 0001127602-23-012330 · form4.xml · nonDerivative · entry 2

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,952

SEC source: 0001127602-23-012330 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,948

F1 · shares: Comprised of 1,398 time-based restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest ratably over a three-year period as of the first, second and third anniversaries of the grant date.

SEC source: 0001127602-23-008326 · form4.xml · nonDerivative · entry 2

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,550

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F3 · price: This transaction was executed in multiple trades at prices ranging from $233.50 to $234.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-008326 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,954

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F2 · price: This transaction was executed in multiple trades at prices ranging from $232.49 to $232.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-005316 · form4.xml · nonDerivative · entry 3

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,050

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F3 · price: This transaction was executed in multiple trades at prices ranging from $247.55 to $247.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-005316 · form4.xml · nonDerivative · entry 2

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,410

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

SEC source: 0001127602-23-005316 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,610

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F2 · price: This transaction was executed in multiple trades at prices ranging from $245.33 to $246.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-23-004047 · form4.xml · derivative · entry 4

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,333.0992

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 107.0746 shares

Expires not disclosed

F2 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F3 · shares: Includes restricted share units acquired pursuant to the Company's contribution under the terms of the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account.

F2 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F2 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

SEC source: 0001127602-23-004047 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,050

F1 · shares: Represents the number of performance-based restricted share units earned upon the certification of the achievement of certain pre-established performance goals based on three-year annualized total shareholder return during the three-year performance period that ended on December 31, 2022, each of which earned unit represents the right to receive one ordinary share of the Issuer upon the satisfaction of the service-based vesting requirement on July 20, 2023, subject to the terms of the award agreement. This number also includes the number of ordinary shares of the Issuer that are issuable pursuant to the dividend equivalent right under the terms of the award agreement providing for the accrual of dividends in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units.

SEC source: 0001127602-23-001817 · form4.xml · derivative · entry 4

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13.72

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 3.924 shares

Expires not disclosed

F6 · derivative.exercise_price: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F6 · shares: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F6 · derivative.exercise_date: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F6 · derivative.expiration_date: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

SEC source: 0001127602-23-001817 · form4.xml · derivative · entry 3

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,226.0246

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 13.6959 shares

Expires not disclosed

F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F5 · shares: Represents dividends acquired pursuant to the Company's contribution under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account in the form of restricted share units.

F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

SEC source: 0001127602-23-001817 · form4.xml · derivative · entry 2

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,807.0276

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 6.7859 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Represents dividends acquired pursuant to the Company's matching contribution on the participant's deferral pursuant to the terms of the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees and credited to the participant's account in the form of restricted share units.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-23-001817 · form4.xml · derivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,800.2417

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 63.6892 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Represents dividends acquired under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees pursuant to the participant's deferral election and automatic deferral of earned awards under the Company's Long-Term Incentive Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-23-001342 · form4.xml · derivative · entry 2

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,736.5525

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 22.5381 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-23-001342 · form4.xml · derivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,714.0144

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 38.6366 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-22-026260 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,355

F1 · price: This transaction was executed in multiple trades at prices ranging from $234.88 to $235.195. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-025277 · form4.xml · derivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,212.3286

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 118.834 shares

Expires not disclosed

F1 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F2 · shares: Includes restricted share units acquired pursuant to the Company's contribution under the terms of the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account.

F1 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F1 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

SEC source: 0001127602-22-024732 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,355

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F2 · price: This transaction was executed in multiple trades at prices ranging from $218.87 to $219.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-22-024151 · form4.xml · derivative · entry 4

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9.796

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 4.76 shares

Expires not disclosed

F6 · derivative.exercise_price: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F6 · shares: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F6 · derivative.exercise_date: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F6 · derivative.expiration_date: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

SEC source: 0001127602-22-024151 · form4.xml · derivative · entry 3

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,093.4946

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 16.1463 shares

Expires not disclosed

F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F5 · shares: Represents dividends acquired pursuant to the Company's contribution under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account in the form of restricted share units.

F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

SEC source: 0001127602-22-024151 · form4.xml · derivative · entry 2

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,675.3779

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 8.1224 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Represents dividends acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees and credited to the participant's account in the form of restricted share units.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-22-024151 · form4.xml · derivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,667.2555

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 77.0755 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Represents dividends acquired under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees pursuant to the participant's deferral election and automatic deferral of earned awards under the Company's Long-Term Incentive Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-22-023845 · form4.xml · derivative · entry 2

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,590.18

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 27.8697 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-22-023845 · form4.xml · derivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,562.3103

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 47.7765 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan").

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

SEC source: 0001127602-22-023723 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,755

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.